Financhill
Back

TScan Therapeutics Stock Predictions

TScan Therapeutics Stock Forecast

  • Is TScan Therapeutics Stock Undervalued?
    The current TScan Therapeutics [TCRX] share price is $3.07. The Score for TCRX is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • TCRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will TScan Therapeutics Stock Go Up Next Year?

Data Unavailable

TScan Therapeutics Stock Rating

Data Unavailable

TScan Therapeutics Stock Price History

Is TCRX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TCRX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tscan.com

52-Week Data

52-Week High:
9.69
52-Week Low:
2.60

Prediction Charts

Market Cap:
173.2M
Price in USD:
3.07
Volume:
315.3K
Beta:
0.93

Technical Analysis

SMA50:
4.20
SMA100:
4.86
SMA200:
6.16
52-Wk Change:
-45.94%

Stock Predictions

  • Is TScan Therapeutics stock public?
    Yes, TScan Therapeutics is a publicly traded company.
  • What is the TScan Therapeutics stock quote today?
    The TScan Therapeutics stock price is 3.07 USD today.
  • How to buy TScan Therapeutics stock online?
    You can buy TScan Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-13 3.03 2.85 3.10 2.82
Dec-16 2.88 3.01 3.06 2.88
Dec-17 3.15 2.97 3.15 2.91
Dec-18 3.02 2.90 3.10 2.81
Dec-19 2.92 2.93 3.03 2.85
Dec-20 2.91 2.97 3.05 2.87
Dec-23 3.10 3.01 3.10 2.92
Dec-24 3.01 2.91 3.01 2.88
Dec-26 3.43 3.11 3.43 2.96
Dec-27 3.06 3.06 3.17 2.96
Dec-30 3.05 3.00 3.10 2.95
Dec-31 3.00 3.04 3.12 2.95
Jan-2 3.07 3.09 3.18 3.03
Jan-3 3.09 3.07 3.21 3.05

TScan Therapeutics Earnings

Data Unavailable

TScan Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.08 per share.

* TScan Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.